← Back to companies
✚ Biotech

Recursion RXRX

Biotech using AI and automation to discover drugs.

Live chart · TradingView

What it does

Runs millions of automated experiments per week, images cells and uses supercomputing and AI to find drug candidates. Merged with Exscientia in 2024.

Ticker
NASDAQ:RXRX
Headquarters
Salt Lake City, EUA
Founded
2013
Evidence Radar

✓ Evidence

  • One of the largest proprietary biological datasets in the sector.
  • Partnerships with big pharma and NVIDIA.

◷ Promises

  • Discover drugs faster and cheaper than the traditional way.

⚠ What could go wrong

  • No approved drug yet.
  • Program cuts after weak results.

Educational content. Not a recommendation to buy or sell any asset.